Systemic Lupus Erythematosus Combined with Acute Cardiovascular Events : a Single Center Retrospective Study for 63 Cases
Chao-juan ZHU,Chao LI,Zhu-sheng FENG,Tian-xing HANG,Xian-qi WANG,Jun-jie LI
DOI: https://doi.org/10.3969/j.issn.1002-3429.2017.07.019
2017-01-01
Abstract:Objective To investigate incidence of cardiovascular events in patients with systemic lupus erythematosus (SLE), and to perform preliminary analysis for clinical characteristics and risk factors of acute heart failure (AHF) in order to provide research basis for prevention of SLE patients with acute cardiovascular events in emergency department.Methods Clinical data of SLE patients with acute cardiovascular events admitted during July 26th 2012 and July 22nd 2016 was analyzed by a single center retrospective study.Risk factors of SLE patients with acute cardiovascular events were analyzed by logistic regression analysis.Results Incidence rate of SLE patients with acute cardiovascular events was 17.17% (63/367) in the recent 4 years.The 63 patients visited doctors for dyspnea, chest pain and expiratory dyspnea, and duration of pathogenesy to visiting in emergency department was 4 (1, 12.5)d.There were 38 patients with AHF, 12 patients with peripheral angiopathy, 8 patients with acute coronary syndrome (ACS, included 4 patients with acute myocardial infarction), 3 patients with pericardial effusion and 1 patient with frequent ventricular premature beats and 1 patient with hypertrophic cardiomyopathy.Duration of this time pathogenesy to diagnosis of SLE was 4.25 (1, 8.25) years.In this study, 1 patient died (1.59%), and 62 patients had stable conditions after treatment, in which 21 patients (33.33%) were discharged, 11 patients (17.46%) were transferred to other hospitals, and less than 50% of all patients were transferred to other relevant departments for continued treatment.Logistic regression analysis showed that hypertension history was the risk factor of SLE patients combined with AHF (P=0.005, OR=10.536, 95% CI:2.023, 54.871);hyperlipidemia history(P=0.040, OR=0.111, 95% CI:0.014, 0.900), abnormal platelet counts (P=0.049, OR=0.990, 95% CI:0.981, 1.000) and valvular heart diseases (P=0.041, OR=0.151, 95% CI:0.025, 0.925) were the protective factors of SLE patients combined with AHF.Conclusion Clinical manifestations of SLE patients with cardiovascular events are especial, and therefore the therapy should be different from ordinary cardiovascular patients, and clinicians should improve understanding and research of cardiovascular events in SLE patients.